Ketamine for Treatment-Resistant Depression

January 04, 2017

Have you been diagnosed with major depression? Do you continue to have symptoms despite medication? If so, you may be interested to learn more about a clinical research study that is being conducted to evaluate an investigational medication for treatment-resistant depression. We are currently enrolling patients for a clinical research study to look at the effectiveness and dosing requirements of an investigational medication that may help with the symptoms of depression. This trial will also explore the safety and tolerability of the investigational medication. This study will last up to 12 months. You may qualify if you meet the following criteria:

  • Are 18 to 64 years of age
  • Have a current diagnosis of Major Depression
  • Experiencing symptoms of depression despite current medication (or previous medication)

Additional criteria will be assessed by the study doctor to confirm your eligibility for this study. All study-related office visits, medical examinations, and study medication will be provided to qualified study participants at no cost. Financial compensation for time and travel may be provided. For more information contact the Clinical Trials Unit at 860.545.7502 or email [email protected].

MSK_ClinicalTrials_Ad